PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1985 June; 78(6): 474–477.
PMCID: PMC1289778

Sublingual isoprenaline in treatment of primary pulmonary hypertension: discussion paper.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (692K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ackroyd JF. Treatment of severe anaphylactic reactions to insect stings. J R Soc Med. 1981 Aug;74(8):567–569. [PMC free article] [PubMed]
  • Anderson AA, Lees GM. Investigation of occurrence of tolerance to bronchodilator drugs in chronically pretreated guinea-pigs. Br J Pharmacol. 1976 Mar;56(3):331–338. [PMC free article] [PubMed]
  • Pelman MJ, Tiep BL, Westinghouse WD. Isoproterenol in pulmonary hypertension. N Engl J Med. 1978 Jan 5;298(1):51–52. [PubMed]
  • Bourdillon PD, Oakley CM. Regression of primary pulmonary hypertension. Br Heart J. 1976 Mar;38(3):264–270. [PMC free article] [PubMed]
  • Daoud FS, Reeves JT, Kelly DB. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol. 1978 Nov;42(5):817–822. [PubMed]
  • DODGE HT, LORD JD, SANDLER H. Cardiovascular effects of isoproterenol in normal subjects and subjects with congestive heart failure. Am Heart J. 1960 Jul;60:94–105. [PubMed]
  • Fujii A, Rabinovitch M, Matthews EC. A case of spontaneous resolution of idiopathic pulmonary hypertension. Br Heart J. 1981 Nov;46(5):574–577. [PMC free article] [PubMed]
  • Harvey JE, Baldwin CJ, Wood PJ, Alberti KG, Tattersfield AE. Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) 1981 May;60(5):579–585. [PubMed]
  • Harvey JE, Tattersfield AE. Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax. 1982 Apr;37(4):280–287. [PMC free article] [PubMed]
  • Hermiller JB, Bambach D, Thompson MJ, Huss P, Fontana ME, Magorien RD, Unverferth DV, Leier CV. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. Ann Intern Med. 1982 Oct;97(4):480–489. [PubMed]
  • Holgate ST, Stubbs WA, Wood PJ, McCaughey ES, Alberti KG, Tattersfield AE. Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond) 1980 Sep;59(3):155–161. [PubMed]
  • Simoons ML. Exercise stress testing. N Engl J Med. 1978 Jan 5;298(1):52–53. [PubMed]
  • KAUFMAN J, IGLAUER A, HERWITZ GK. Effect of isuprel (isopropylepinephrine) on circulation of normal man. Am J Med. 1951 Oct;11(4):442–447. [PubMed]
  • Lupi-Herrera E, Bialostozky D, Sobrino A. The role of isoproterenol in pulmonary artery hypertension of unknown etiology (primary): short- and long-term evaluation. Chest. 1981 Mar;79(3):292–296. [PubMed]
  • Pantano JA. Isoproterenol in primary pulmonary hypertension. N Engl J Med. 1980 Apr 17;302(16):919–920. [PubMed]
  • Paterson JW, Conolly ME, Davies DS, Dollery CT. Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet. 1968 Aug 24;2(7565):426–429. [PubMed]
  • Pietro DA, LaBresh KA, Shulman RM, Folland ED, Parisi AF, Sasahara AA. Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol. N Engl J Med. 1984 Apr 19;310(16):1032–1034. [PubMed]
  • Satyanarayana Rao BN, Moller JH, Edwards JE. Primary pulmonary hypertension in a child. Response to pharmacologic agents. Circulation. 1969 Oct;40(4):583–587. [PubMed]
  • Rich S, Ganz R, Levy PS. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension. Am J Cardiol. 1983 Nov 1;52(8):1104–1107. [PubMed]
  • Rich S, Martinez J, Lam W, Levy PS, Rosen KM. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. Am Heart J. 1983 Jan;105(1):119–127. [PubMed]
  • Shettigar UR, Hultgren HN, Specter M, Martin R, Davies DH. Primary pulmonary hypertension favorable effect of isoproterenol. N Engl J Med. 1976 Dec 16;295(25):1414–1415. [PubMed]
  • Wang SW, Pohl JE, Rowlands DJ, Wade EG. Diazoxide in treatment of primary pulmonary hypertension. Br Heart J. 1978 May;40(5):572–574. [PMC free article] [PubMed]
  • Warrell DA, Robertson DG, Howes JN, Conolly ME, Paterson JW, Beilin LJ, Dollery CT. Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J. 1970 Jan 10;1(5688):65–70. [PMC free article] [PubMed]
  • Wood BA, Tortoledo F, Luck JC, Fennell WH. Rapid attenuation of response to nifedipine in primary pulmonary hypertension. Chest. 1982 Dec;82(6):793–794. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press